S14G-Humanin improves cognitive deficits and reduces amyloid pathology in the middle-aged APPswe/PS1dE9 mice
- 1 January 2012
- journal article
- Published by Elsevier BV in Pharmacology Biochemistry and Behavior
- Vol. 100 (3), 361-369
- https://doi.org/10.1016/j.pbb.2011.09.012
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China
This publication has 52 references indexed in Scilit:
- Soluble Aβ levels correlate with cognitive deficits in the 12-month-old APPswe/PS1dE9 mouse model of Alzheimer's diseaseBehavioural Brain Research, 2011
- A Humanin Derivative Reduces Amyloid Beta Accumulation and Ameliorates Memory Deficit in Triple Transgenic MicePLOS ONE, 2011
- The Pharmacoeconomics of Cognitive Enhancers in Moderate to Severe Alzheimerʼs DiseaseCNS Drugs, 2010
- RS-0406 Arrests Amyloid-β Oligomer-Induced Behavioural Deterioration In VivoBehavioural Brain Research, 2010
- β-Secretase Inhibitor Potency Is Decreased by Aberrant β-Cleavage Location of the “Swedish Mutant” Amyloid Precursor ProteinPublished by Elsevier BV ,2010
- Neural stem cells improve cognition via BDNF in a transgenic model of Alzheimer diseaseProceedings of the National Academy of Sciences, 2009
- PET amyloid ligand [ 11 C]PIB uptake is increased in mild cognitive impairmentNeurology, 2007
- Humanin Is a Novel Neuroprotective Agent Against StrokeStroke, 2006
- Glatiramer acetate fights against Alzheimer’s disease by inducing dendritic-like microglia expressing insulin-like growth factor 1Proceedings of the National Academy of Sciences, 2006
- Reconstitution of γ-secretase activityNature, 2003